Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.84836 | 64 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.84921 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.78087 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.80563 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.37938 | 70 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.9078 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.81259 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.519 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.52129 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.83411 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.82718 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.8186 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.77878 | 63 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.85889 | 64 |